Growth and Factors Affecting it in Thalassemia Major

REFERENCES

• Anita S. Growth retardation in thalassemia major patients. Int J Hum Genet. 2003;3(4):237–246.
   Google Scholar
• Soliman AT, ElZalabany MM, Amer M, Ansari BM. Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study. J Trop Pediatr. 1999;45(1):23–30.
   PubMed Web of Science ®Google Scholar
• Karlberg J, Jalil F, Lam B, Low L, et al. Linear growth retardation in relation to the three phases of growth. In: John C. Waterlow, Bent Schürch, eds. Causes and Mechanisms of Linear Growth Retardation. Proceedings of an I/D/E/G/C Workshop held in London, U.K, January 15–18, 1993. Eur J Clin Nutr. 1993.
   Google Scholar
• Soliman AT. Study of growth and bone mineral density and factors affecting them in children and adolescents with thalassaemia major and sickle cell disease. PhD thesis, The University of Glamorgan, Glamorgan, UK, 1998.
   Google Scholar
• Soliman AT, El-Matary W, Fattah MM, et al. The effect of high-calorie diet on nutritional parameters of children with β-thalassaemia major. Clin Nutr. 2004;23(5):1153–1158.
   Google Scholar
• Soliman AT, El Banna N, Ansari BM. GH Response to Provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I Generation Test and Clinical Response to GH Therapy in Children with Beta-thalassemia. Eur J Endocrinol. 1998;138(4):394–400.
   Google Scholar
• Soliman AT, ElZalabany MM, Mazloum Y, et al. Spontaneous and provoked growth hormone (GH) secretion and insulin-like growth factor I (IGF-I) concentration in patients with beta thalassaemia and delayed growth. J Trop Pediatr. 1999;45(6):327–337.
   Google Scholar
• El-Nanawy AA, el Azzouni OF, Soliman AT, Amer AE, Demian RS, El-Sayed HM. Prevalence of Hepatitis-C antibody seropositivity in healthy Egyptian children and four high risk groups. J Trop Pediatr. 1995;41(6):341–343.
   PubMedGoogle Scholar
• Wu KH, Tsai FJ, Peng CT. Growth hormone (GH) deficiency in patients with ß-thalassemia major and the efficacy of recombinant GH treatment. Ann Hematol. 2003;82(10):637–640.
   Google Scholar
• Geffner ME, Karlsson H. Use of recombinant human growth hormone in children with thalassemia. Horm Res. 2009;71(l):46–50.
   Google Scholar
• Oerter KE, Kamp GA, Munson PJ, Nienhaus AW, Cassorla FG, Manasco PK. Multiple hormone deficiencies in children with hemochromatosis. J Clin Endocrinol Metab. 1993;76:357–361.
   PubMed Web of Science ®Google Scholar
• Grundy RG, Wood KA, Savage MO, Evan JPM. Relationship of endocrinopathy to iron chelation status in young patients with thalassemia major. Arch Dis Child. 1994;74:128–132.
   Google Scholar
• Bucuvalas JC, Cutfield W, Horn J, et al. Resistance to the growth promoting effects of growth hormone in children with chronic liver disease. J Pediatr. 1990;117:397–402.
   Google Scholar
• Soliman AT, Nasr I, Thabet A, Rizk MM, El Matary W. Human chorionic gonadotropin therapy in adolescent boys with constitutional delayed puberty vs those with β-thalassemia major. Metabolism. 2005;54:15–24.
   PubMed Web of Science ®Google Scholar
• Soliman AT, elZalabany MM, Ragab M, et al. Spontaneous and GnRH-provoked gonadotropin secretion and testosterone response to human chorionic gonadotropin in adolescent boys with thalassaemia major and delayed puberty. J Trop Pediatr. 2000;46(2):79–85.
   Google Scholar
• Soliman AT, El Banna N, Abdel Fattah M, ElZalabani MM, Ansari BM. Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data. Metabolism. 1998;47(5):541–548.
   Google Scholar
• Raiola G, Galati MC, De Sanctis V, et al. Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab. 2003;16(Suppl. 2):259–266.
   PubMedGoogle Scholar
• Saka N, Sükür M, Bundak R, Anak S, Neyzi O, Gedikoğlu G. Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab. 1995;8(3):181–186.
   PubMed Web of Science ®Google Scholar
• Constantoulakis M, Panagopoulos G, Augoustaki O. Stature and longitudinal growth in thalassemia major. A study of 229 Greek patients. Clin Pediatr (Phila). 1975;14(4):355–368.
   Google Scholar
• Kwan EYW, Lee ACW, Li AMC, et al. A cross-sectional study of growth, puberty and endocrine function in patients with thalassemia major in Hong Kong. J Pediatr Child Health. 1995;31:83–87.
   Google Scholar
• Shehadeh N, Hazani A, Rudolf MC, Peleg I, Benderly A, Hochberg Z Neurosecretory dysfunction of growth hormone secretion in thalassemia major. Acta Paediatr Scand. 1990;79(8–9):790–795.
   Google Scholar
• Spiliotis BE, Chrysis DC, Alexandrides TK, Georgopoulos N, Koromantzou EV, Beratis NG. IGF-I generation test as a potential marker of growth hormone neurosecretory dynamics in b-thalassemia. Program and Abstracts of the 10th International Congress of Endocrinology, San Francisco CA, USA, June 12–15, 1996;( Abstract P1–P127).
   Google Scholar
• Argyropoulou MI, Kiortsis DN, Efremidis SC. MRI of the liver and the pituitary gland in patients with β-thalassemia major: Does hepatic siderosis predict pituitary iron deposition? Eur Radiol. 2003;13(1):12–16.
   Google Scholar
• Argyropoulou MI, Metafratzi Z, Kiortsis DN, Bitsis S, Tsatsoulis A, Efremidis S. T2 relaxation rate as an index of pituitary iron overload in patients with beta-thalassemia major. AJR Am J Roentgenol. 2000;175(6):1567–1569.
   PubMed Web of Science ®Google Scholar
• Au WY, Lam W, Chu W, et al. A cross-sectional MRI T2* study of pancreatic and pituitary hemosiderosis in 180 thalassemia major patients in Hong Kong. ASH Annual Meeting Abstracts. 2007;110(11):2771.
   Google Scholar
• Chrysis DC, Spiliotis BE, Alexandrides TK, Makri M, Beratis NG. Growth hormone and insulin-like growth factor dynamics in thalassemia major. Program and Abstracts of the 77th Annual Meeting of the Endocrine Society, Washington DC, USA, June 14–17, 1995; ( Abstract P1–175).
   Google Scholar
• Blum WF, Cotterill AM, Postel-Vinay MC, Ranke MB, Savage MO, Wilton P. Improvement of diagnostic criteria in growth hormone. insensitivity syndrome: solutions and pitfalls. Acta Paediatrica. 1994;399(Suppl.):117–124.
   Google Scholar
• Low LCK. Growth, puberty and endocrine function in beta-thalassaemia major. J Pediatr Endocrinol Metab. 1997;10:175–184.
   PubMed Web of Science ®Google Scholar
• Kwan EYW, Tam SCF, Cheung PT, Low LCK. The effect of 3 years of recombinant growth hormone therapy on glucose metabolism in short Chinese children with β-thalassemia major. J Pediatr Endocrinol Metab. 2000;13:545–552.
   Google Scholar
• Low LCK, Kwan EYW, Cheung PT. Final height of growth hormone treated non-GH deficient children with β-thalassemia major. Proceedings of the Endocrine Society 81st Annual Meeting, San Diego, California. June 12, 1999.
   Google Scholar
• Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, et al. Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia. J Clin Endocrinol Metab. 2003;88:3966–3972.
   PubMed Web of Science ®Google Scholar
• De Sanctis V, Stea S, Savarino1 L, et al. Osteochondrodystrophic lesions in chelated thalassemic patients: an histological analysis. Calcif Tissue Int. 2000;67(2):134–140.
   Google Scholar
• Chand G, Chowdhury V, Manchanda A, Singh S. Deferiprone-induced arthropathy in thalassemia: MRI findings in a case. Indian J Radiol Imaging. 2009;19(2):155–157.
   Google Scholar
• Theodoridis C, Ladis V, Papatheodorou A, et al. Growth and management of short stature in thalassemia major. J Pediatr Endocrinol Metab. 1998;11(Suppl. 3):835–844.
   Google Scholar
• Soliman A, Adel A, Wagdy M, Al Ali M, ElMulla N. Calcium homeostasis in 40 adolescents with beta-thalassemia major: a case-control study of the effects of intramuscular injection of a megadose of cholecalciferol. Pediatr Endocrinol Rev. 2008;6(Suppl. 1):146–149.
   Google Scholar
• Arcasoy A, Canata D, Sinav B, et al. Serum zinc levels and zinc binding capacity in thalassemia. J Trace Elem Med Biol. 2001;15:85–87. HMC Document Delivery Bibliographic Links External Resolver [Context Link].
   PubMed Web of Science ®Google Scholar
• Arcasoy A, Çavdar A, Cin S, et al. Effects of zinc supplementation on linear growth in beta-thalassemia (A new approach). Am J Hematol. 1986;24(2):127–136.
   Google Scholar
• Yesilipek MA, Hazar V, Yegin O. L-carnitine treatment in beta thalassemia major. Acta Haematol. 1998;100:33, 162–163
   Google Scholar